Antiretroviral drugs; Developing countries; Drug safety; HIV/AIDS; KwaZulu-Natal; Medicines; Pharmacovigilance; Sentinel-site surveillance and Side-effects

Evaluating adverse drug reactions among HAART patients in a resource-constraint province of South Africa

Abstract